[Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]

  • R J Haas
  • F J Helmig
  • H Hausner
  • R Eife
  • K Devens
  • Gritta Janka-Schaub
  • M Helmig
  • F Lampert

Abstract

78 children with Wilms' tumor stage I--IV diagnosed since 1960 are presented. There were two groups of patients: one group consisting of 35 patients which received adjuvant chemotherapy for 1 year, the other group consisting of 43 patients which received no chemotherapy. Surgical excision and irradiation was identical in both groups. The prognosis was greatly improved by adjuvant chemotherapy: 4-year survival rates increased from 25 to 69%. Late side effects from radiation and chemotherapy were noted: 15/78 patients suffered from scoliosis and all patients treated by chemotherapy had a decreased lymphotoxin activity over years. The following factors appear to be related to prognosis: the extent of disease in patients determined by better techniques, histopathology of the tumor, and the nature of treatment.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer2
ISSN0378-584X
StatusVeröffentlicht - 1982
pubmed 6285242